We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biovail Sues to Block Andrx's Planned Cardizem LA Generic
Biovail Sues to Block Andrx's Planned Cardizem LA Generic
August 23, 2005
Biovail Laboratories has filed a lawsuit against Andrx Pharmaceuticals, alleging that Andrx’s planned generic version of hypertension treatment Cardizem LA infringes Biovail’s patent on the drug.